LOCUS       ABV15245.1               608 aa    PRT              BCT 31-JAN-2014
DEFINITION  Citrobacter koseri ATCC BAA-895 hypothetical protein protein.
ACCESSION   CP000822-4066
PROTEIN_ID  ABV15245.1
SOURCE      Citrobacter koseri ATCC BAA-895
  ORGANISM  Citrobacter koseri ATCC BAA-895
            Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
            Enterobacteriaceae; Citrobacter.
REFERENCE   1  (bases 1 to 4720462)
  AUTHORS   McClelland,M., Sanderson,E.K., Porwollik,S., Spieth,J.,
            Clifton,W.S., Latreille,P., Courtney,L., Wang,C., Pepin,K.,
            Bhonagiri,V., Nash,W., Johnson,M., Thiruvilangam,P. and Wilson,R.
  CONSRTM   The Citrobacter koseri Genome Sequencing Project
  TITLE     Direct Submission
  JOURNAL   Submitted (29-AUG-2007) Genetics, Genome Sequencing Center, 4444
            Forest Park Parkway, St. Louis, MO 63108, USA
COMMENT     Citrobacter (diversus) koseri--Citrobacter cells are isolated from
            water, sewage, soils, and food, as well as from the feces of man
            and other animals, where they may be normal inhabitants. They can
            be found in urine, sputum, and other clinical specimens. They can
            sometimes be opportunistic pathogens particularly in
            immunocompromised patients in hospitals or in infants (Pepperell et
            al., Antimicrob Agents Chemother. 2002 Nov;46(11):3555-60. and
            references therein).
            
            The strain of Citrobacter koseri being sequenced, strain CDC
            4225-83, was isolated in 1983 in Maryland, where it caused neonatal
            meningitis. It was provided by Caroline Mohr and Melissa Campbell
            of CDC. The strain is available from the American Type Culture
            Collection as ATCC BAA-895 or from the Salmonella Genetic Stock
            Centre as SGSC4696. The genome was sequenced to 8X coverage, using
            plasmid and fosmid libraries and was finished to an error rate of
            less than 1 per 10,000 bases. Automated annotation was performed
            and manual annotation will continue in the labs of Michael
            McClelland and Kenneth Sanderson. The National Institute of Allergy
            and Infectious Diseases (NIAID), National Institutes of Health
            (NIH) has funded this project.
            
            Coding sequences below are predicted using GeneMark v3.3 and
            Glimmer2 v2.13.Intergenic regions not spanned by GeneMark and
            Glimmer2 were blasted against NCBI's non-redundant (NR) database
            and predictions generated based on protein alignments. RNA genes
            were determined usingtRNAscan-SE 1.23 or Rfam v8.0. This sequence
            was finished as follows unless otherwise noted: all regions were
            double stranded, sequenced with an alternate chemistries or covered
            by high quality data (i.e., phred quality >=30); an attempt was
            made to resolve all sequencing problems, such as compressions and
            repeats; all regions were covered by sequence from more than one
            m13 subclone.
FEATURES             Qualifiers
     source          /organism="Citrobacter koseri ATCC BAA-895"
                     /mol_type="genomic DNA"
                     /strain="ATCC BAA-895"
                     /db_xref="ATCC:BAA-895"
                     /db_xref="taxon:290338"
     protein         /locus_tag="CKO_04184"
                     /inference="protein motif:HMMSmart:IPR003593"
                     /inference="protein motif:HMMTigr:IPR006344"
                     /inference="similar to AA sequence:INSD:CAD02817.1"
                     /note="KEGG: stt:t2901 2.0e-284 recD; exonuclease V
                     alpha-subunit K03581; COG: COG0507 ATP-dependent exoDNAse
                     (exonuclease V), alpha subunit - helicase superfamily I
                     member"
                     /transl_table=11
                     /db_xref="InterPro:IPR003593"
                     /db_xref="InterPro:IPR006344"
BEGIN
        1 MTIQKRLLEA VEQKLLRPLD AQFALAVAGQ DDPCVTLAVA LLSRDAGEGH VCMPLSRLAI
       61 TEESHPLLVS WFSERDVPED WASCLLASGA VSRGERPTPL ILHEDRLYLN RMWSNERTVA
      121 RFFSEVNQAI AVDEQQLART LDALFPPTDD VNWQKVAAAV ALTRRISVIS GGPGTGKTTT
      181 VAKLLAALIQ MADGERCRIR LAAPTGKAAA RLTESLGAAL RQLPLTDEQK KRIPDDASTL
      241 HRLLGAQPGS QRLRHHAGNP LHLDVLVVDE ASMIDLPMMS RLIEALPPHG RVIFLGDRDQ
      301 LASVEAGAVL GDICAWVNAG FTAGRAQQLS RLTGSPIPAG AGTEAASLRD SLCLLQKSYR
      361 FGHDSGIGQL AAAINCGDKA AMKTVFQQGF SDIEKRTLQS SEDYAAMLDE ALAGYGRYLA
      421 LVREGAEPGA IIQAFNEYQL LCALREGPFG VGGLNERIEQ VMLQKRKIQR HPHSRWYEGR
      481 PVMIARNDSA LGLFNGDIGI ALDRGQGLRV WFAMPDGSIK SVQPSRLPEH ETTWAMTVHK
      541 SQGSEFDHAA LILPSQRSPV VTRELVYTAV TRARRRLSLY ADERVLSGAI ATRTERRSGL
      601 SAFFNNGL
//